MyFinsight
Home
Blog
About
Investment securities,
amortized cost of...
$1,150,275K
(0.67%↑ Y/Y)
Cash and cash
equivalents
$55,498K
(3.30%↑ Y/Y)
Prepaid expenses and
other current assets
$23,144K
(13.43%↑ Y/Y)
Trade accounts
receivable, net
$11,957K
Inventory
$3,488K
Total current assets
$1,244,362K
(2.23%↑ Y/Y)
Operating lease
right-of-use assets
$39,107K
(-6.67%↓ Y/Y)
Prepaid expenses and
other assets, net of...
$24,541K
(64.29%↑ Y/Y)
Property and equipment,
net
$13,073K
(-10.89%↓ Y/Y)
Restricted cash, net of
current portion
$800K
(0.00%↑ Y/Y)
Total assets
$1,321,883K
(2.51%↑ Y/Y)
Total liabilities and
stockholders equity
$1,321,883K
(2.51%↑ Y/Y)
Total stockholders
equity
$1,191,962K
(1.74%↑ Y/Y)
Total liabilities
$129,921K
(10.06%↑ Y/Y)
Accumulated deficit
-$1,666,127K
(-43.07%↓ Y/Y)
Accumulated other
comprehensive (loss) income
-$3,008K
(-285.56%↓ Y/Y)
Stock held in trust
$1,263K
(1027.68%↑ Y/Y)
Common stock and
paid-in capital, 0.001...
$2,862,360K
(22.61%↑ Y/Y)
Total current
liabilities
$79,915K
(16.84%↑ Y/Y)
Operating lease
liabilities, non-current
$40,606K
(-6.28%↓ Y/Y)
Other liabilities
$5,935K
(154.28%↑ Y/Y)
Deferred revenue,
non-current
$3,465K
(-13.20%↓ Y/Y)
Accounts payable and
accrued expenses
$42,439K
(11.43%↑ Y/Y)
Accrued compensation
and related...
$29,222K
(34.07%↑ Y/Y)
Operating lease
liabilities
$6,585K
(-0.38%↓ Y/Y)
Deferred revenue
$1,669K
(-12.34%↓ Y/Y)
Back
Back
Balance Sheet
Crinetics Pharmaceuticals, Inc. (CRNX)
Crinetics Pharmaceuticals, Inc. (CRNX)
source: myfinsight.com